Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02093637 · ClinicalTrials.gov registry record · NA

Rapid Extremity Pain Relief by Battlefield Acupuncture After Orthopedic Surgery

A NA study, sponsored by Mike O'Callaghan Military Hospital.

Completed
Registry status
NA
Development phase
279
Enrollment target

NCT02093637: Completed NA study, sponsored by Mike O'Callaghan Military Hospital.

NCT02093637 is a NA study that has completed, run by Mike O'Callaghan Military Hospital. The registered enrollment target is 279 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (80% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02093637, a NA study, has completed, sponsored by Mike O'Callaghan Military Hospital.

COMPLETED
Registry status
NA
Development phase
279 participants
Enrollment target

Study Summary

The purpose of this study is to determine if the addition of Battlefield Auricular Acupuncture (BFA) to standard therapy causes reduction in pain, medication use, time to ambulation without assistance, hours missed from work and increases quality of life after lower extremity surgery at two Air Force Medical Centers.

Interventions

  • OTHER Battlefield Acupuncture
  • OTHER Placebo acupuncture

Trial Details

FieldValue
Enrollment Target 279 participants
Start Date 2013-08
Est. Completion 2017-02
Phase NA
Mike O'Callaghan Military Hospital

26 total trials

What the finished NCT02093637 record still lists

NCT02093637 is an interventional study that assigns participants to a tested intervention. The registered 279 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (80% lower).

The record links to 0 conditions, and to 2 interventions - of which Battlefield Acupuncture is the first listed.

NCT02093637 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT02093637 about?

NCT02093637 is a clinical study titled "Rapid Extremity Pain Relief by Battlefield Acupuncture After Orthopedic Surgery". The purpose of this study is to determine if the addition of Battlefield Auricular Acupuncture (BFA) to standard therapy causes reduction in pain, medication use, time to ambulation without assistance, hours missed from work and increases quality of life after lower extremity surgery at two Air Forc...

What is the current status of trial NCT02093637?

This trial is currently completed. It is a NA study. The enrollment target is 279 participants. The study started on 2013-08. Estimated completion is 2017-02.

What interventions are being tested in trial NCT02093637?

The interventions under investigation include: Battlefield Acupuncture (OTHER), Placebo acupuncture (OTHER).

Who is sponsoring clinical trial NCT02093637?

This trial is sponsored by Mike O'Callaghan Military Hospital, which has 26 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT02093637's enrollment target sits among peer trials

279 381st of 2000 higher than 1,619 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT04783857 · 279 participants · Phase 4

    Modifying Progesterone and Estradiol Levels to Prevent Postpartum Cigarette Smoking Relapse and Reduce Secondhand Smoke Exposure in Infants and Children

  • NCT05407324 · 279 participants · Phase 2

    Dazucorilant in Patients With Amyotrophic Lateral Sclerosis

  • NCT06299748 · 279 participants

    A Worldwide Pregnancy Safety Study to Assess Maternal, Fetal, and Infant Outcomes Following Exposure to Efgartigimod During Pregnancy and/or Breastfeeding.

  • NCT06582784 · 279 participants · NA

    IMPACT (IMproving Proactive Approaches for Cancer Survivors' Mental Health Treatment)

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02093637, the US trial registry maintained by the National Library of Medicine. NCT02093637 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.